Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,834,308
-$4,141,833 QoQ
Shares Held
194,725
-43.8% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Dec 31, 2024CallValue
$1,215,980
CallShares
65,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. FTRE ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in FTRE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,834,308 | 194,725 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,976,141 | 346,443 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,959,039 | 351,430 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $2,409,004 | 487,653 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $2,406,026 | 318,679 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $8,687,673 | 465,827 | Shares | Sole | 2026-03-19 | |
| 2024-12-31 | $1,215,980 | 65,200 | Call | Sole | 2026-03-19 | |
| 2024-09-30 | $7,850,080 | 392,504 | Shares | Sole | 2026-03-31 | |
| 2024-09-30 | $1,304,000 | 65,200 | Call | Sole | 2026-03-31 | |
| 2024-06-30 | $1,400,400 | 60,000 | Call | Sole | 2026-03-23 | |
| 2024-06-30 | $1,268,528 | 54,350 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,620,940 | 65,295 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $771,464 | 22,105 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $16,391,646 | 573,335 | Shares | Sole | 2026-03-26 | |
| No filing history on record for this holder in this stock. | ||||||